Scilex Holding (SCLXW) Shareholder's Equity (QoQ) (2020 - 2026)

Scilex Holding (SCLXW) Shareholder's Equity (QoQ) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Scilex Holding - - 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -22.28%
Dec 31, 2025 -17.43%
Sep 30, 2025 28.94%
Jun 30, 2025 -17.73%
Mar 31, 2025 -9.78%
Dec 31, 2024 8.84%
Sep 30, 2024 1.57%
Jun 30, 2024 -13.12%
Mar 31, 2024 -9.74%
Dec 31, 2023 -6.31%
Sep 30, 2023 -1,661.57%
Jun 30, 2023 -5.95%
Mar 31, 2023 -69.44%
Dec 31, 2022 115.80%
Sep 30, 2022 9.00%
Jun 30, 2022 -8.86%
Mar 31, 2022 -3.44%
Dec 31, 2021 -2,177.53%
Sep 30, 2021 -17.22%
Jun 30, 2021 -2.87%